14124 Federal Register / Vol. 72, No. 57 / Monday, March 26, 2007 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Proposed Collection: 

Comment Request 

In compliance with the requirement 

for opportunity for public comment on 

proposed data collection projects 

(section 3506(c)(2)(A) of Title 44, United 

States Code, as amended by the 

Paperwork Reduction Act of 1995, Pub. 

L. 104–13), the Health Resources and 

Services Administration (HRSA) 

publishes periodic summaries of 

proposed projects being developed for 

submission to the Office of Management 

and Budget (OMB) under the Paperwork 

Reduction Act of 1995. To request more 

information on the proposed project or 

to obtain a copy of the data collection 

plans and draft instruments, call the 

HRSA Reports Clearance Officer on 

(301) 443–1129. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. 

Proposed Project: The National Health 

Service Corps (NHSC) Scholarship 

Program Deferment Request Forms and 

Associated Reporting Requirements 

(OMB No. 0915–0179): Extension 

The National Health Service Corps 

(NHSC) Scholarship program was 

established to assure an adequate 

supply of trained primary care health 

professionals to the neediest 

communities in Health Professional 

Shortage Areas (HPSAs) of the United 

States. Under the program, allopathic 

physicians, osteopathic physicians, 

dentists, nurse practitioners, nurse 

midwives, physician assistants, and, if 

needed by the NHSC program, students 

of other health professions enter into a 

contractual agreement with the 

Secretary under which the Public 

Health Service agrees to pay the total 

school tuition, required fees and a 

stipend for living expenses. In 

exchange, the scholarship recipient 

agrees to provide full-time clinical 

services at a site in a federally 

designated HPSA. 

Once the scholars have met their 

academic requirements, the law requires 

that individuals receiving a degree from 

a school of medicine or osteopathic 

medicine must (and all others may) 

request a deferment of their service 

obligation to complete approved 

internship, residency or other advanced 

nursing training consistent with the 

needs of the NHSC. The Deferment 

Request Form and Letter of Intent and 

Request provide the information 

necessary for considering the period and 

type of training for which deferment of 

the service obligation is requested. 

The annual estimate of burden is as 

follows: 

Form Number of 

respondents 

Responses 

per 

respondent 

Total 

responses 

Hours per 

response 

Total burden 

hours 

Deferment Request Form .................................................... 600 1 600 1 600 

Letters of Intent and Request .............................................. 100 1 100 1 100 

Total .............................................................................. 700 ........................ 700 ........................ 700 

Send comments to Susan G. Queen, 

Ph.D., HRSA Reports Clearance Officer, 

Room 10–33, Parklawn Building, 5600 

Fishers Lane, Rockville, MD 20857. 

Written comments should be received 

within 60 days of this notice. 

Dated: March 19, 2007. 

Alexandra Huttinger, 

Acting Director, Division of Policy Review 

and Coordination. 

[FR Doc. E7–5414 Filed 3–23–07; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Government-Owned Inventions; 

Availability for Licensing 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: The inventions listed below 

are owned by an agency of the U.S. 

Government and are available for 

licensing in the U.S. in accordance with 

35 U.S.C. 207 to achieve expeditious 

commercialization of results of 

federally-funded research and 

development. Foreign patent 

applications are filed on selected 

inventions to extend market coverage 

for companies and may also be available 

for licensing. 

ADDRESSES: Licensing information and 

copies of the U.S. patent applications 

listed below may be obtained by writing 

to the indicated licensing contact at the 

Office of Technology Transfer, National 

Institutes of Health, 6011 Executive 

Boulevard, Suite 325, Rockville, 

Maryland 20852–3804; telephone: 301/ 

496–7057; fax: 301/402–0220. A signed 

Confidential Disclosure Agreement will 

be required to receive copies of the 

patent applications. 

Rapid Universal and/or Type-Specific 

Assay for Clostridium Botulinum 

Description of Technology: The urgent 

need for a rapid diagnostic test capable 

of detecting all serotypes of C. 

botulinum is well known. Botulinum 

neurotoxins (BoNTs) are the most potent 

biological toxins known and are 

categorized as category A biodefense 

agents because of lethality and ease of 

production. Current diagnostic methods 

include clinical observation of 

symptoms that could be mistaken for 

other neurological conditions and a 

mouse protection bioassay that takes as 

long as four days and has a number of 

disadvantages. The subject technology 

utilizes unique PCR primers for the 

detection of the non-toxin nonhemaglutinin (NTNH) gene of C. 

botulinum; this gene is highly 

conserved in all C. botulinum toxin 

types and subtypes. Thus, samples that 

contain botulinum can be determined 

regardless of serotype involved, 

providing a universal means of 

diagnosis. Further, the technology 

describes different PCR primers and 

flurogenic probes for a BoNT-specific 

assay. The type-specific assay can be 

used independently or in conjunction 

with the universal assay described 

above. The universal and type-specific 

assays were successfully used first to 


cprice-sewell on PROD1PC66 with NOTICES